切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 241 -245. doi: 10.3877/cma.j.issn.1674-0785.2019.04.001

所属专题: 文献

临床研究

硫辛酸对不同时期糖尿病肾病患者尿微量白蛋白及炎症的影响
石锋1,(), 吴豫梅1, 曾黄辉1, 吴永新1, 王红梅1   
  1. 1. 514031 广东梅州,梅州市人民医院内分泌科
  • 收稿日期:2018-12-22 出版日期:2019-02-15
  • 通信作者: 石锋
  • 基金资助:
    梅州市科技计划项目(2015B027)

Effect of lipoic acid on urinary microalbumin and inflammation in patients with diabetic nephropathy at different stages

Feng Shi1,(), Yumei Wu1, Huanghui Zeng1, Yongxin Wu1, Hongmei Wang1   

  1. 1. Department of Endocrinology, Meizhou People′s Hospital, Meizhou 514031, China
  • Received:2018-12-22 Published:2019-02-15
  • Corresponding author: Feng Shi
  • About author:
    Corresponding author: Shi Feng, Email:
引用本文:

石锋, 吴豫梅, 曾黄辉, 吴永新, 王红梅. 硫辛酸对不同时期糖尿病肾病患者尿微量白蛋白及炎症的影响[J/OL]. 中华临床医师杂志(电子版), 2019, 13(04): 241-245.

Feng Shi, Yumei Wu, Huanghui Zeng, Yongxin Wu, Hongmei Wang. Effect of lipoic acid on urinary microalbumin and inflammation in patients with diabetic nephropathy at different stages[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(04): 241-245.

目的

探讨硫辛酸对不同时期糖尿病肾病患者尿微量白蛋白和炎症的影响。

方法

选取2015年7月至2017年12月在梅州市人民医院内分泌科住院治疗的2型糖尿病患者90例,根据24 h尿微量白蛋白排泄率(UAER)分为3组,即正常白蛋白尿组(NA,UAER<30 mg/24 h)、微量白蛋白尿组(MA,30 mg/24 h≤UAER<300 mg/24 h)和临床肾病组(CN,UAER≥300 mg/24 h);同时随机选取同期健康体检者30名作为正常对照组(NC)。再将3组糖尿病患者按随机数字表法随机分为等样本量的观察组和对照组,对照组给予常规治疗,观察组在常规治疗基础上给予注射用硫辛酸0.45 g加入0.9 %氯化钠注射液250 ml中避光缓慢静滴,1次/d,共2周。观察各组患者UAER、血清肌酐(SCr)、血糖、血清超敏C反应蛋白(hs-CRP)、血清肿瘤坏死因子α(TNF-α)水平的变化。

结果

2型糖尿病肾病患者血清hs-CRP、TNF-α水平明显高于正常对照组[(5.98±1.54)mg/L vs (6.49±1.84)mg/L vs(7.02±1.75)mg/L vs(2.95±0.86)mg/L;(17.19±5.05)ng/L vs(19.61±5.42)ng/L vs (20.25±6.23)ng/L vs (10.24±3.16)ng/L],差异具有统计学意义(F=15.63、25.22,P均<0.01),但糖尿病肾病不同时期比较差异无统计学意义;观察组经硫辛酸治疗后与对照组治疗后比较,其hs-CRP、TNF-α、SCr、UAER水平明显降低[(5.01±0.93)mg/L vs (3.89±0.72)mg/L,(5.51±1.23)mg/L vs (4.25±0.88)mg/L,(6.15±1.32)mg/L vs (4.78±1.01)mg/L;(15.59±4.19)ng/L vs (12.04±3.45)ng/L,(18.02±4.42)ng/L vs (14.43±4.22)ng/L,(18.67±4.88)ng/L vs (15.09±4.47)ng/L;(83.5±9.4)μmol/L vs (67.3±6.2)μmol/L,(85.6±16.0)μmol/L vs (61.3±16.7)μmol/L,(98.5±20.4)μmol/L vs (69.4±16.8)μmol/L;(16.5±7.4)mg/24 h vs(13.3±6.2)mg/24 h,(145.6±66.0)mg/24 h vs (106.3±56.7)mg/24 h,(805.5±166.4)mg/24 h vs(612.3±110.8)mg/24 h],差异具有统计学意义(t=3.689、3.227、3.192、2.526、2.275、2.095、5.572、4.069、4.265、5.597、2.051、3.742,P均<0.05)。

结论

2型糖尿病肾病患者存在炎症反应,硫辛酸可改善2型糖尿病肾病炎症状态,减少尿微量白蛋白排泄和降低血肌酐水平,从而达到肾保护作用。

Objective

To investigate the effect of lipoic acid on urinary microalbumin and inflammation in patients with diabetic nephropathy at different stages.

Methods

Ninety patients with type 2 diabetes who were hospitalized at the Department of Endocrinology, Meizhou People's Hospital from July 2015 to December 2017 were selected, and they were divided into three groups according to 24-hour urinary albumin excretion rate (UAER): normal albuminuria group (NA group, UAER<30 mg/24 h), microalbuminuria group (MA group, 30 mg/24 h≤UAER<300 mg/24 h), and clinical nephropathy group (CN group, UAER≥300 mg/24 h). At the same time, we randomly selected 30 patients who underwent physical examination as a normal control group (NC group). Then, the three groups of diabetes patients were randomly and equally divided into an observation group and a control group using a random number table. The control group was given conventional treatment. The observation group was given 0.45 g lipoic acid for injection plus 0.9% sodium chloride injection 250 mL by slow intravenous infusion, once a day for 2 weeks. The changes of UAER, serum creatinine (SCr), blood glucose, hs-CRP, and TNF-α levels were observed.

Results

The levels of serum hs-CRP and TNF-α in the three groups of patients with type 2 diabetic nephropathy were significantly higher than those in the NC group [(5.98±1.54) mg/L, (6.49±1.84) mg/L, (7.02±1.75) mg/L vs (2.95±0.86) mg/L, F=15.63, P<0.01; (17.19±5.05) ng/L, (19.61±5.42) ng/L, (20.25±6.23) ng/L vs (10.24±3.16) ng/L, F=25.22, P<0.01]; however, there was no significant difference among the three groups of patients with type 2 diabetic nephropathy. The levels of hs-CRP, TNF-α, SCr, and UAER were decreased significantly after lipoic acid treatment in the observation groups than in the control groups [(5.01±0.93) mg/L vs (3.89±0.72) mg/L, (5.51±1.23) mg/L vs (4.25±0.88) mg/L, (6.15±1.32) mg/L vs (4.78±1.01) mg/L, t=3.689, 3.227, 3.192, P<0.05; (15.59±4.19) ng/L vs (12.04±3.45) ng/L, (18.02±4.42) ng/L vs (14.43±4.22) ng/L, (18.67±4.88) ng/L vs (15.09±4.47) ng/L, t=2.526, 2.275, 2.095, P<0.05; (83.5±9.4) μmol/L vs (67.3±6.2) μmol/L, (85.6±16.0) μmol/L vs (61.3±16.7) μmol/L, (98.5±20.4) μmol/L vs (69.4±16.8) μmol/L, t=5.572, 4.069, 4.265, P<0.05; (16.5±7.4) mg/24 h vs (13.3±6.2) mg/24 h, (145.6±66.0) mg/24 h vs (106.3±56.7) mg/24 h, (805.5±166.4) mg/24 h vs (612.3±110.8) mg/24 h, t=5.597, 2.051, 3.742, P<0.05].

Conclusion

The inflammatory reaction exists in type 2 diabetic nephropathy patients. Lipoic acid can protect the kidney by improving the inflammatory state of type 2 diabetic nephropathy, reducing urinary microalbumin excretion, and lowering serum creatinine levels.

表1 3组糖尿病患者一般临床资料比较
表2 治疗前各组血清TNF-α、hs-CRP水平的比较(±s
表3 各组糖尿病患者治疗后血糖、血肌酐、UAER、hs-CRP和TNF-α水平的比较(±s
1
Kawanami D, Utsunomiya K. Epidemiology of diabetic nephropathy [J]. Nihon Rinsho, 2016, 74 Suppl 2: 153-157.
2
张敏杰,刘畅,方翼. 糖尿病肾病肾组织的自噬与凋亡及炎症的相互关系 [J]. 中国临床药理学杂志, 2017, 33(19): 1972-1975.
3
袁晓英,王晓娜,江蓓. α-硫辛酸治疗早期糖尿病肾病患者的临床研究 [J]. 中国临床药理学杂志, 2016, 32(14): 1276-1278.
4
Bhattacharjee N, Barma S, Konwar N, et al. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update [J]. Eur J Pharmacol, 2016, 791: 8-24.
5
Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy [J]. Nat Rev Nephrol, 2011, 7(6): 327-340.
6
Gupta S, Mehndiratta M, Kalra S, et al. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-alpha levels and susceptibility to diabetic nephropathy in North Indian population [J]. J Diabetes Complications, 2015, 29(3): 338-342.
7
毕逢辰,保莉,罗红艳, 等. 血清肿瘤坏死因子α在2型糖尿病肾病中的表达及作用 [J]. 宁夏医学杂志, 2018, 40(3): 274-276.
8
石锋,吴永新. 硫辛酸对早期糖尿病肾病患者尿微量白蛋白及炎症的影响 [J/CD]. 中华临床医师杂志(电子版), 2016, 10(4): 491-493.
9
钱超,刘峻宏,刘晨, 等. 糖尿病肾病不同进展阶段血清炎症因子的检测与分析 [J]. 当代医学, 2018, 24(10): 36-39.
10
邬亦华,龙泉,石晓欣, 等. 糖尿病肾病患者脂肪因子、炎症因子的检测及意义 [J]. 国际检验医学杂志, 2018, 39(9): 1128-1130.
11
奚敏慧,赵歆辉,朱爱国, 等. α-硫辛酸对糖尿病肾病患者氧化应激, Hcy, CysC的影响 [J]. 现代生物医学进展, 2017, 17(8): 1457-1460.
12
Gomes MB, Negrato CA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases [J]. Diabetol Metab Syndr, 2014, 6(1): 80.
13
Lin H, Ye S, Xu J, et al.The alpha-lipoic acid decreases urinary podocalyxin excretion in type 2 diabetics by inhibiting oxidative stress in vivo [J]. J Diabetes Complications, 2015, 29(1): 64-67.
14
陈敏,程丽霞. 硫辛酸联合缬沙坦治疗早期糖尿病肾病及改善炎症进程的疗效观察 [J/CD]. 中华临床医师杂志(电子版), 2018, 12(2): 75-79.
15
Hong Y, Peng J, Cai X, et al. Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy [J]. Open Med (Wars), 2017, 12: 323-327.
[1] 诸琴红, 夏典平, 葛芳娣, 崔大伟. 抗氧化和炎症指标在糖尿病肾病患者中的临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 307-311.
[2] 费扬, 赵晗希, 孙丽琴, 楼琴华, 胡骏程. 银杏叶提取物对糖尿病肾病患者的疗效及其对尿液外泌体miR-342-3p的干预研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 219-224.
[3] 中华医学会器官移植学分会, 中国医疗保健国际交流促进会肾脏移植学分会. 中国胰肾联合移植临床诊疗指南[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 129-147.
[4] 杜贵伟, 陆勇, 成博, 贺薏, 梁爽. 钬激光碎石术术后联合坦索罗辛治疗对输尿管结石患者的影响分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 491-496.
[5] 高娟, 徐建庆, 闫芳, 丁盛华, 刘霞. Rutkow、TAPP、TEP 手术治疗单侧腹股沟疝患者的临床疗效及对血清炎症因子水平的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 675-680.
[6] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[7] 汤畅通, 王永楠, 王诗筌. 颅脑外伤后阵发性交感神经兴奋患者的药物治疗效果分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 233-237.
[8] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[9] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[10] 李秀玲, 连少锋, 荣刘涛, 李登峰, 饶蕴玉. 利巴韦林联合复方嗜酸乳杆菌治疗轮状病毒肠炎患儿的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 369-372.
[11] 白璐, 李青霞, 冯一卓, 刘雪倩, 刘若琪, 曲卓敏, 赵凌霞. 丁酸盐治疗糖尿病肾病的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 303-308.
[12] 买买提·依斯热依力, 尹强, 尹海龙, 李治建, 董雨微, 王永康, 克力木·阿不都热依木, 阿吉艾克拜尔·艾萨. 罗乐胃蜜膏抑制酸刺激诱导食管上皮细胞炎症发生的机制研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 137-142.
[13] 张梅, 陈卉, 李转霞, 王瑞, 李林娟. Metrnl和NLRP3炎症小体:糖尿病肾病的潜在诊断标志物[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 193-199.
[14] 欧春影, 李晓宾, 郭靖, 朱亮, 许可, 王梦, 安晓雷. 丁苯酞对血管性认知障碍大鼠炎症因子的影响及对认知障碍的改善作用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 483-487.
[15] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
阅读次数
全文


摘要